BioSpace News Archive

OliX Pharmaceuticals, Inc. today announced that the Company has selected Pharmaron to conduct non-clinical toxicity studies to evaluate the safety of OLX703A, OliX’s investigational therapeutic for hepatitis B (HBV).

Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today presentations of nonclinical data and patient and caregiver feedback that support the Company’s clinical programs for mucopolysaccharidosis type II (MPS II), or Hunter syndrome, and phenylketonuria (PKU).

Axsome to host conference call and webcast on Monday, November 8, 2021 at 8:00 AM Eastern Time

SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), today announced that it has entered into a collaboration agreement with Ab Magnitude Ventures Group, LLC and Ab Magnitude Fund, LP (collectively, “Ab Magnitude”) for the development of next-generation targeted oncology therapeutics.

Monte Rosa Therapeutics, Inc. today announced that Sharon Townson, Ph.D., Chief Technology Officer, will present at the virtual 4th Annual Targeted Protein Degradation Summit on Wednesday, Oct. 27 at 11:45 a.m. ET.

F-star Therapeutics, Ltd. today announced that it has entered into a license and collaboration agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

BioDelivery Sciences International, Inc. announced today that it will report its third quarter 2021 financial results before the open of the U.S. financial markets on Wednesday, November 3, 2021.

AmMax Bio, Inc. today announced positive interim data from a Phase 2 study of AMB-05X for the treatment of tenosynovial giant cell tumor (TGCT).

RELIEF THERAPEUTICS Holding SA announced that its wholly owned subsidiary, APR Applied Pharma Research SA, reported two papers published in the peer reviewed Journal of Wound Care, concluding that the company’s Nexodyn acid-oxidizing solution, developed with APR’s proprietary Tehclo technology, may represent a valuable therapeutic addition to standard of care for the management of hard-to-heal ulcers requiring long periods of treatment.

AI in medical diagnostics is the integration of deep learning, data insights, and algorithms for the early detection of life-threatening and critical diseases to ensure preventive treatment and quality analysis.